Market price today
hVIVO plc (HVO-L) Stock Price & Analysis
Gross Profit Margin
Operating Profit Margin
Net Profit Margin
Return on Assets
Return on Equity
Return on Capital Employed
Company general description and statistics
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers. The Disease in Motion platform has various potential applications across a range of end users, including big technology, wearables, pharma, and biotech companies. Further, the company provides preclinical and early clinical research services; sales and marketing services; and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC (chemistry, manufacturing, and controls), and PK and medical writing to a range of European clients. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.
Return on Investments
Frequently Asked Question
How many company shares are outstanding in 2023?
There are stock number shares outstanding of hVIVO plc (HVO.L) on the LSE in 2023.
What is P/E ratio of enterprise in 2023?
The current P/E ratio of enterprise is -175.518 in 2023.
What is the ticker symbol of hVIVO plc stock?
The ticker symbol of hVIVO plc stock is HVO.L.
What is company IPO date?
IPO date of hVIVO plc is 2012-12-14.
What is company current share price?
Current share price is 20.300 GBp.
What is stock market cap today?
The market cap of stock today is 138115510.000.
What is PEG ratio in 2023?
The current -840.357 is -840.357 in 2023.
What is the number of employees in 2023?
In 2023 the company has 210.